Latest Update (as of September 28, 2026): Federal spinal cord stimulator cases against Boston Scientific have been centralized in MDL No. 3181 in the Central District of California since June 5, 2026. In early September, the FDA announced a Class I recall of Boston Scientific Infinion CX leads after more than 1,000 serious injuries were reported. The Judicial Panel on Multidistrict Litigation was scheduled to hear arguments on September 24, 2026, on whether to create separate MDLs for Abbott and Nevro cases, and we found no ruling yet. No settlements or verdicts against the manufacturers have been publicly reported.
Last updated: September 2026
Thousands of patients are fighting back against spinal cord stimulator manufacturers in 2026. The spinal cord stimulator lawsuit targets devices made by Abbott, Medtronic, Nevro, and Boston Scientific that allegedly caused serious injuries including nerve damage, burns, shocks, and paralysis.
If you had one of these devices implanted and something went wrong, this article breaks down everything you need to know. You’ll find settlement estimates, eligibility details, recall information, and step-by-step filing instructions.
The FDA has received over 100,000 adverse event reports tied to spinal cord stimulators since 2008. That number keeps climbing.
By the end of this page, you’ll know whether you qualify, which manufacturers face the most claims, and what kind of money people are actually recovering.
What Is the Spinal Cord Stimulator Lawsuit?
The spinal cord stimulator lawsuit is a collection of product liability cases filed against manufacturers whose implanted pain-relief devices allegedly harmed patients. These lawsuits claim that companies sold defective neurostimulation devices while downplaying serious risks.
A spinal cord stimulator is a small device surgically implanted near the spine. It sends electrical pulses to block pain signals. When the device works correctly, it can be life-changing for chronic pain sufferers.
But when it fails, the consequences are devastating. Patients have reported involuntary shocks, lead wires snapping inside the body, and permanent nerve damage that leaves them worse off than before surgery.
| Key Detail | Information |
|---|---|
| Type of Lawsuit | Product liability, mass tort |
| Defendants | Abbott, Medtronic, Nevro, Boston Scientific |
| Primary Allegations | Design defect, failure to warn, negligence |
| Number of FDA Reports | Over 100,000 adverse events |
| Status in 2026 | Active litigation, cases being filed |
The legal theory is straightforward. Manufacturers had a duty to design safe devices and warn patients about known risks. Plaintiffs argue that these companies failed on both counts.
Some cases allege that clinical trial data was manipulated. Others claim the companies aggressively marketed to doctors while burying complication reports.
Spinal Cord Stimulator Lawsuit Update for 2026
As of 2026, spinal cord stimulator litigation is intensifying across multiple fronts. New cases continue to be filed in federal and state courts, and several manufacturer-specific lawsuits are moving toward critical pretrial phases.
Abbott faces the largest volume of claims. Cases against the company (and its predecessor St. Jude Medical) have been consolidated in certain jurisdictions. Bellwether trials, which serve as test cases to gauge jury reactions, are expected to shape settlement negotiations throughout the year.
Medtronic litigation has picked up steam after additional recall actions in late 2025. Nevro cases remain smaller in number but are growing as more patients report battery failures and lead fractures with Senza devices.
- Abbott cases: Largest docket; bellwether trials anticipated in 2026
- Medtronic cases: Growing after 2025 recall expansions
- Nevro cases: Increasing complaint volume through 2026
- Boston Scientific cases: Steady filings related to Precision Spectra and WaveWriter models
Statute of limitations deadlines vary by state. Some patients who were injured years ago may be running out of time to file. 2026 is a critical window for anyone still considering legal action.
Legal experts anticipate that initial settlement frameworks could emerge by late 2026, especially if bellwether verdicts favor plaintiffs.
Is There a Spinal Cord Stimulator Class Action Lawsuit?
There is no single certified class action lawsuit for spinal cord stimulators as of 2026. Most cases are being handled as individual lawsuits or through mass tort proceedings.
People often confuse class actions with mass torts. In a class action, one lawsuit represents everyone. In a mass tort, each person files their own case, but the cases are grouped together for efficiency.
Spinal cord stimulator claims fit the mass tort model better. Each patient’s injuries are different. One person might have lead migration. Another might have third-degree burns. A class action would lump everyone together, which wouldn’t reflect the individual harm.
| Legal Structure | How It Works | Applies Here? |
|---|---|---|
| Class Action | One case represents all plaintiffs | No |
| Mass Tort | Individual cases grouped for pretrial | Yes |
| MDL (Multidistrict Litigation) | Federal cases consolidated before one judge | Partially |
| Individual Lawsuit | Filed alone in state or federal court | Yes |
Some cases have been consolidated through multidistrict litigation, or MDL, in federal court. This lets one judge handle discovery and pretrial motions for dozens or hundreds of cases at once.
Even without a class action label, the mass tort approach often leads to global settlements. If manufacturers decide to settle, they typically negotiate a deal that covers all qualified plaintiffs at once.
Key Takeaway: Spinal cord stimulator lawsuits in 2026 are active mass tort cases, not class actions, with bellwether trials on the horizon and statute of limitations deadlines closing for many patients.
Spinal Cord Stimulator Lawsuit Settlement Amounts
Estimated settlement amounts for spinal cord stimulator lawsuits range from $75,000 to over $1 million per case, depending on injury severity. No global settlements have been finalized as of early 2026.
These numbers are projections based on similar medical device cases, individual settlements that have already been reached privately, and the severity tiers that legal analysts expect manufacturers to offer.
The wide range reflects a simple reality. Someone who needed one revision surgery has a very different case than someone who ended up paralyzed.
| Injury Tier | Estimated Settlement Range | Example Injuries |
|---|---|---|
| Tier 1 (Severe) | $500,000 to $1,500,000+ | Paralysis, permanent nerve damage |
| Tier 2 (Serious) | $200,000 to $500,000 | Multiple revision surgeries, chronic pain worsening |
| Tier 3 (Moderate) | $75,000 to $200,000 | Single revision surgery, temporary nerve damage |
| Tier 4 (Minor) | $25,000 to $75,000 | Device removal only, minor complications |
Several factors influence where your case falls on the spectrum:
- Severity of injury: Permanent damage commands higher compensation
- Number of surgeries: Each revision adds to your damages
- Lost wages: Time off work or inability to return to your career
- Medical bills: Out-of-pocket costs for treatment and follow-up care
- Pain and suffering: Emotional distress and loss of quality of life
Past medical device settlements offer useful benchmarks. Hip implant cases settled for averages between $200,000 and $400,000. Transvaginal mesh cases averaged $60,000 to $150,000. Spinal cord stimulator cases, given the proximity to the spinal cord and the severity of potential injuries, are expected to trend higher.
Abbott Spinal Cord Stimulator Lawsuit
The Abbott spinal cord stimulator lawsuit is the largest segment of SCS litigation in 2026. Abbott, which acquired St. Jude Medical in 2017, inherited a portfolio of neurostimulation devices and a growing list of patient complaints.
Devices at the center of Abbott’s litigation include the Proclaim XR, Proclaim DRG, and older St. Jude Medical models. Patients allege these devices delivered uncontrolled electrical shocks, caused thermal burns to spinal tissue, and had leads that fractured or migrated after implantation.
The FDA’s MAUDE database shows tens of thousands of adverse event reports linked to Abbott and St. Jude Medical neurostimulators. Many reports describe patients receiving jolting shocks during everyday activities like bending over, coughing, or sleeping.
| Abbott Device | Key Allegations |
|---|---|
| Proclaim XR | Uncontrolled stimulation, battery failures |
| Proclaim DRG | Lead migration, nerve damage |
| St. Jude Eon Mini | Overheating, thermal burns |
| Burst DR | Involuntary shocks during MRI procedures |
Abbott has issued multiple field safety notices over the years. Critics argue that these notices came too late and did not adequately warn patients about the scope of the problem.
One of the core allegations is that Abbott’s internal testing revealed higher-than-expected failure rates. Plaintiffs claim the company pushed ahead with sales anyway, prioritizing revenue over patient safety.
If you received an Abbott or St. Jude Medical spinal cord stimulator and experienced any device malfunction, you may have a viable claim.
Medtronic Spinal Cord Stimulator Lawsuit
The Medtronic spinal cord stimulator lawsuit involves claims against the world’s largest medical device manufacturer. Patients allege that Medtronic neurostimulators caused serious injuries due to design flaws and manufacturing defects.
Medtronic’s Intellis and RestoreSensor platforms are the most frequently cited devices in litigation. The Intellis system, marketed as a rechargeable and MRI-compatible stimulator, has drawn complaints about battery malfunctions and unexpected device shutdowns.
The RestoreSensor, which uses an internal accelerometer to adjust stimulation based on body position, has been linked to reports of uncontrolled stimulation changes. Patients describe sudden painful jolts when shifting positions or lying down.
- Intellis: Battery swelling, loss of therapy, device lockouts
- RestoreSensor: Position-triggered shocks, lead fractures
- SureFit Anchors: Anchor failures leading to lead migration
- Vanta Series: Early reports of programming glitches
Medtronic issued a Class I recall (the most serious type) for certain SureFit lead anchoring components. The recall affected thousands of patients whose leads could shift position inside the spinal canal, potentially causing nerve compression or loss of pain relief.
Plaintiffs argue that Medtronic knew about design problems with its anchoring system but delayed the recall. The company’s internal communications are a focus of discovery in ongoing litigation.
Medtronic’s global scale means thousands of patients worldwide may be affected. In the U.S., federal and state court filings continue to increase heading into 2026.
Key Takeaway: Abbott and Medtronic face the highest volume of spinal cord stimulator claims, with Abbott’s Proclaim line and Medtronic’s Intellis and RestoreSensor systems drawing the most serious allegations of device failure and patient harm.
Nevro Spinal Cord Stimulator Lawsuit
The Nevro spinal cord stimulator lawsuit centers on the company’s Senza and Senza II high-frequency stimulation systems. Nevro, a smaller company compared to Abbott and Medtronic, positioned its HF10 therapy as a breakthrough in pain management.
Patients filing claims against Nevro allege that the Senza devices failed prematurely, delivered inconsistent therapy, and caused injuries that required surgical removal. Battery life issues are among the most common complaints.
Nevro marketed the Senza system as providing “superior pain relief without paresthesia,” meaning patients wouldn’t feel tingling sensations during therapy. Some plaintiffs argue this marketing overstated the device’s effectiveness while minimizing risks of device failure.
| Nevro Device | Reported Issues |
|---|---|
| Senza | Premature battery depletion, loss of therapy |
| Senza II | Lead fractures, inconsistent stimulation |
| Omnia | Connection failures with external components |
A key allegation in Nevro cases involves the company’s clinical trial data. Plaintiffs claim Nevro selectively presented trial results to the FDA and physicians, highlighting benefits while downplaying complication rates documented during studies.
The number of Nevro lawsuits is smaller than Abbott or Medtronic cases. But legal experts expect growth in 2026 as more Senza patients reach the 3 to 5 year mark when device failures tend to surface.
If you received a Nevro Senza implant and experienced early battery failure or required a revision surgery, your case could have merit.
Boston Scientific Spinal Cord Stimulator Lawsuit
The Boston Scientific spinal cord stimulator lawsuit involves the company’s Precision Spectra and WaveWriter Alpha neurostimulation systems. Boston Scientific holds a significant share of the SCS market, and patient complaints have generated a growing number of legal claims.
Precision Spectra cases often involve allegations of lead migration, where the thin wires implanted near the spine shift out of position. When leads migrate, therapy becomes ineffective or painful. Some patients report that migrated leads caused direct nerve compression.
The WaveWriter Alpha, a newer device, has drawn complaints about software glitches and unexpected therapy changes. Patients describe the device changing stimulation levels on its own, sometimes delivering painful bursts without warning.
- Precision Spectra: Lead migration, connector failures, revision surgeries
- WaveWriter Alpha: Software errors, involuntary stimulation changes
- Precision Novi: Battery swelling, overheating reports
Boston Scientific has faced FDA enforcement actions related to manufacturing quality at its production facilities. Inspection reports have cited issues with quality control processes and complaint handling procedures.
Compared to Abbott and Medtronic, Boston Scientific litigation is at an earlier stage. Many cases are still being investigated and prepared for filing. Patients who experienced problems with Boston Scientific devices should act in 2026 before statute of limitations windows close.
Spinal Cord Stimulator Complications Behind the Lawsuit
Spinal cord stimulator complications are the driving force behind every lawsuit in this litigation. These devices, once implanted, sit millimeters from delicate spinal nerves. When something goes wrong, the consequences can be permanent.
The FDA categorizes spinal cord stimulators as Class III medical devices, the highest risk classification. They require premarket approval because of the potential for serious injury. Despite this classification, complication rates have alarmed both patients and regulators.
Studies published in medical journals have documented complication rates ranging from 30% to 40% across all SCS brands. That means roughly one in three patients experiences some type of problem with their device.
| Complication | Frequency | Severity |
|---|---|---|
| Lead migration | 13% to 23% | Moderate to severe |
| Infection at implant site | 3% to 8% | Moderate |
| Hardware malfunction | 3% to 10% | Varies |
| Unwanted stimulation | 10% to 15% | Moderate |
| Pain at implant site | 5% to 12% | Mild to moderate |
| Lead fracture | 5% to 9% | Severe |
What makes these complications especially troubling is that many patients received stimulators as a last resort. They were already suffering from chronic pain. The device was supposed to help. Instead, some patients ended up in worse condition than before.
Lawsuits allege that manufacturers were aware of these complication rates but failed to communicate them honestly to patients and doctors. Informed consent documents allegedly minimized or omitted known failure data.
Key Takeaway: Complication rates for spinal cord stimulators run as high as 40%, and lawsuits allege that manufacturers intentionally downplayed these risks to keep selling devices.
Common Spinal Cord Stimulator Injuries
The most common spinal cord stimulator injuries include nerve damage, uncontrolled electrical shocks, infections, lead fractures, and in the worst cases, partial or full paralysis. These injuries form the basis of nearly every SCS lawsuit filed in 2026.
Think of it this way. Your spinal cord is the body’s information superhighway. Placing an electronic device next to it is like doing construction on a live highway. If a wire shifts even a few millimeters, the results can be catastrophic.
Here are the injuries most frequently cited in litigation:
- Nerve damage: Compressed, irritated, or severed nerves causing new pain, numbness, or weakness
- Paralysis: Partial or complete loss of movement in limbs
- Electrical shocks: Sudden, painful jolts from device malfunction
- Burns: Thermal injuries from overheating devices or leads
- Infection: Surgical site infections sometimes requiring hospitalization
- Chronic pain worsening: Device fails and leaves patient in more pain than before implantation
- Psychological harm: Depression, anxiety, PTSD from traumatic device experiences
Many patients describe a common pattern. The device works reasonably well for the first year. Then problems begin. The lead shifts. Stimulation patterns change. Pain returns, sometimes worse than before.
By the time the device is removed, permanent damage may already be done. Scar tissue around the leads can create new pain sources that persist even after explant surgery.
Spinal Cord Stimulator Shock and Burn Injuries
Spinal cord stimulator shock and burn injuries are among the most frightening complications reported by patients. These injuries occur when the device delivers electrical energy in unintended ways, either through malfunction, lead damage, or software errors.
Shock injuries happen when the device sends a sudden surge of electricity through the leads. Patients describe the sensation as being tased from inside their body. Some shocks are strong enough to cause muscle spasms, falls, and loss of consciousness.
Burn injuries are caused by overheating. When a device’s battery malfunctions or a lead develops a short circuit, the resulting heat can burn spinal tissue, muscle, and skin from the inside out. Some patients have required treatment for second and third-degree internal burns.
| Injury Type | Cause | Reported Outcomes |
|---|---|---|
| Electrical shock | Device malfunction, lead short circuit | Muscle spasms, falls, nerve damage |
| Thermal burn | Battery overheating, IPG malfunction | Tissue damage, scarring, chronic pain |
| Involuntary stimulation | Software error, position sensor glitch | Loss of motor control, panic attacks |
The FDA has received thousands of reports specifically describing shock and burn events. In many cases, patients report that their device began shocking them during routine activities like showering, driving, or sleeping.
These injuries carry both physical and psychological consequences. Patients who’ve been shocked by their own implant often develop severe anxiety. The fear that it could happen again at any moment creates lasting trauma.
Spinal Cord Stimulator Lead Migration Lawsuit
Spinal cord stimulator lead migration is the single most common hardware complication and a central allegation in many lawsuits. Lead migration occurs when the thin electrode wires shift from their original implanted position near the spinal cord.
When leads migrate, the electrical pulses meant to block pain signals now hit the wrong nerves. This can cause new pain in areas that were previously fine. It can cause numbness, tingling, or shooting pain in the legs, arms, or torso.
Studies show that lead migration occurs in 13% to 23% of SCS patients. That’s a staggering rate for a surgically implanted device that costs $30,000 to $50,000.
- Leads can shift due to normal body movement
- Poor anchoring systems increase migration risk
- Scar tissue can push leads out of position
- Some lead designs are more prone to migration than others
Lawsuits targeting lead migration focus on two key theories. First, plaintiffs allege design defects in the leads themselves, arguing that certain designs are inherently unstable. Second, they allege that the anchoring systems provided by manufacturers are inadequate for keeping leads in place.
Medtronic’s SureFit anchor system was the subject of a Class I recall specifically because anchors were failing and allowing leads to migrate. This recall strengthened legal claims against the company and set a precedent for other manufacturers.
The real cost of lead migration is the revision surgery. Each revision means another trip to the operating room, another round of anesthesia, and another risk of complications.
Key Takeaway: Lead migration affects up to 23% of SCS patients and is the most commonly alleged defect in spinal cord stimulator lawsuits, often requiring costly and risky revision surgeries.
Spinal Cord Stimulator Lawsuit Eligibility
You may be eligible for a spinal cord stimulator lawsuit if you had a device implanted and experienced a device malfunction, injury, or complication that required medical intervention. Eligibility depends on several specific factors.
Not every person who had an SCS implant qualifies. The lawsuit isn’t about dissatisfaction with pain relief. It’s about defective devices causing actual harm.
Here are the general eligibility criteria for filing a claim in 2026:
| Eligibility Factor | Requirement |
|---|---|
| Device implanted | Must have received an SCS from Abbott, Medtronic, Nevro, or Boston Scientific |
| Injury documented | Medical records showing device-related injury or complication |
| Timeframe | Implanted and/or injured within statute of limitations window |
| Causation | Injury must be linked to device malfunction, not underlying condition |
| Location | Must be a U.S. resident or have been treated in the U.S. |
Your medical records are the backbone of your case. Hospital records, imaging showing lead position, operative reports from revision surgeries, and documentation of adverse events all serve as evidence.
Even if your device was removed years ago, you may still qualify. The statute of limitations clock typically starts when you discovered (or should have discovered) that the device caused your injury, not when it was implanted.
Who Qualifies for a Spinal Cord Stimulator Lawsuit?
Anyone who received an SCS implant from a named manufacturer and suffered a documented injury from device malfunction may qualify for a spinal cord stimulator lawsuit. The strongest cases involve patients who required revision surgery, explant surgery, or emergency medical treatment.
Here’s a breakdown of who typically qualifies:
- Patients whose leads migrated and required repositioning or removal
- Patients who experienced electrical shocks or involuntary stimulation
- Patients who suffered burns from overheating devices
- Patients who developed infections at the surgical site requiring additional treatment
- Patients who became partially or fully paralyzed after implantation
- Patients whose devices were recalled by the manufacturer
- Patients who underwent revision surgery to replace or remove the device
Family members of patients who died from SCS-related complications may qualify to file wrongful death claims.
You do not need to prove that the manufacturer intentionally harmed you. Product liability law in most states requires only that the device was defective and that the defect caused your injury.
If you aren’t sure whether you qualify, gathering your medical records is the best first step. Surgical reports, imaging studies, and any correspondence with the device manufacturer can all support a claim.
How to File a Spinal Cord Stimulator Lawsuit
Filing a spinal cord stimulator lawsuit in 2026 starts with gathering your medical records and contacting an attorney experienced in medical device litigation. The process is more straightforward than most people expect.
Here’s the typical step-by-step process:
Step 1: Collect your medical records. Get surgical reports, imaging studies, device identification cards, and any records of complications or follow-up treatments.
Step 2: Identify your device. Find out the exact manufacturer, model name, and serial number of your implant. Your implant card or surgical records will have this information.
Step 3: Consult a medical device attorney. Look for a lawyer or firm with specific experience in SCS litigation. Most work on contingency, meaning you pay nothing unless you win.
Step 4: Case evaluation. Your attorney reviews your records, assesses the strength of your claim, and determines which legal theories apply.
Step 5: File the complaint. Your attorney files the lawsuit in the appropriate court. This could be federal court (if joining an MDL) or state court.
Step 6: Discovery and litigation. Both sides exchange evidence. Your attorney builds the case using medical records, expert testimony, and manufacturer documents.
| Filing Step | What You Need |
|---|---|
| Medical records | Surgical reports, imaging, complication records |
| Device identification | Manufacturer name, model, serial number |
| Attorney consultation | Free, no obligation with most firms |
| Filing | Attorney handles all paperwork and court filings |
Most medical device attorneys offer free case evaluations. You won’t pay anything out of pocket to get started.
Key Takeaway: Filing a spinal cord stimulator lawsuit requires your medical records, device identification, and an experienced attorney, and most law firms handle these cases on contingency with no upfront costs.
Spinal Cord Stimulator Recall Updates for 2026
Multiple spinal cord stimulator recalls remain active or newly issued heading into 2026. The FDA has classified several SCS recalls as Class I, indicating a reasonable probability that the product will cause serious adverse health consequences or death.
Here are the most significant recalls affecting patients in 2026:
| Manufacturer | Product | Recall Class | Issue |
|---|---|---|---|
| Medtronic | SureFit Anchors | Class I | Anchor failure causing lead migration |
| Abbott | Certain Proclaim leads | Class I | Lead fracture risk |
| Abbott | St. Jude Eon rechargeable IPG | Class II | Battery swelling and overheating |
| Boston Scientific | Precision Spectra components | Class II | Connector failures |
| Nevro | Senza battery units | Class II | Premature battery depletion |
A recall doesn’t always mean the device is physically taken back from patients. In many cases, the FDA issues a safety communication and the manufacturer sends updated instructions to doctors. For implanted devices, “recall” often means enhanced monitoring or recommendation for early replacement.
If your device is on a recall list, that fact significantly strengthens any legal claim. A recall is essentially the FDA confirming that the device has a problem. It removes the burden of proving a defect on your own.
You can search the FDA’s recall database and the MAUDE adverse event database to see if your specific device model has been flagged. Your device serial number, found on your implant identification card, is the key to checking.
Spinal Cord Stimulator Revision Surgery Lawsuit
Spinal cord stimulator revision surgery lawsuits focus on the cost, pain, and risk of additional surgeries required when an SCS device fails. Revision surgery is one of the most common outcomes when a spinal cord stimulator malfunctions, and it’s a major source of compensable damages.
The average cost of SCS revision surgery in the U.S. ranges from $25,000 to $60,000 per procedure. Some patients require multiple revisions. Others need complete explant surgery where the entire system is removed.
Every additional surgery comes with fresh risks. Anesthesia complications, infection, nerve damage during lead removal, and scar tissue formation are all possibilities each time a surgeon opens the patient back up.
| Revision Type | Average Cost | Common Reason |
|---|---|---|
| Lead repositioning | $25,000 to $35,000 | Lead migration |
| IPG replacement | $30,000 to $45,000 | Battery failure |
| Complete explant | $40,000 to $60,000 | Device removal due to complications |
| Revision with new system | $50,000 to $80,000 | Switching manufacturers |
Lawsuits related to revision surgery argue that patients should never have needed these procedures. If the device had been properly designed, adequately tested, and honestly marketed, the initial implant would have worked as promised.
Damages in revision surgery cases include the cost of each surgery, time off work during recovery, physical therapy expenses, and pain and suffering from undergoing repeated operations. Some patients have had three or more revisions, turning what was supposed to be a one-time solution into a years-long medical ordeal.
The financial and emotional toll of revision surgery is enormous. It’s like buying a car that breaks down every six months and costs more to fix each time. Eventually, the repairs cost more than the car was ever worth.
What You Need to Know About the Spinal Stimulator Lawsuit
The spinal stimulator lawsuit is one of the most significant medical device litigations of 2026. It represents a growing recognition that the SCS industry pushed devices to market too aggressively and failed to protect patients from foreseeable harm.
Here’s the big picture. The spinal cord stimulator market generates over $2 billion annually in the United States alone. Device manufacturers compete fiercely for market share, incentivizing rapid product launches and aggressive marketing to pain management physicians.
That competitive pressure, plaintiffs argue, created a culture where getting devices to market fast mattered more than getting them right. Clinical trials were allegedly designed to highlight benefits while minimizing documented risks.
Quick Facts About the Spinal Stimulator Lawsuit:
- Over 100,000 FDA adverse event reports for SCS devices
- Multiple Class I recalls issued across manufacturers
- Complication rates documented at 30% to 40%
- Individual case settlements estimated at $75,000 to $1,500,000+
- No global settlement reached as of 2026
- Cases being filed in federal and state courts nationwide
The lawsuit isn’t just about broken devices. It’s about a system where patient safety took a back seat to profits. Regulatory gaps, insufficient post-market surveillance, and aggressive marketing practices all contributed to the problem.
For patients living with the consequences of a failed spinal cord stimulator, this litigation represents something important. It’s a chance to hold billion-dollar companies accountable and recover compensation for injuries that never should have happened.
Key Takeaway: The spinal stimulator lawsuit in 2026 targets a $2 billion industry where aggressive marketing and high complication rates have left thousands of patients with serious injuries and the chance to seek meaningful compensation.
Frequently Asked Questions
How much money can I get from a spinal cord stimulator lawsuit in 2026?
Most estimates place individual settlements between $75,000 and $1,500,000 depending on injury severity.
Cases involving paralysis or permanent nerve damage fall at the higher end.
No global settlement has been finalized yet, so exact amounts remain projections based on comparable medical device cases.
What is the deadline to file a spinal cord stimulator lawsuit?
Deadlines depend on your state’s statute of limitations, which typically ranges from 2 to 4 years from when you discovered the injury.
Some states use a “discovery rule” that starts the clock when you learned the device caused your harm.
Contact an attorney in 2026 to confirm your specific deadline before it passes.
Which spinal cord stimulator brands are involved in lawsuits?
The four main manufacturers facing lawsuits are Abbott (St. Jude Medical), Medtronic, Nevro, and Boston Scientific.
Abbott and Medtronic have the highest volume of claims.
Nevro and Boston Scientific cases are growing as more patients report long-term device failures.
Do I need surgery records to file a spinal cord stimulator claim?
Yes, medical records including surgical reports and imaging are essential to proving your case.
Records showing the device implant, any complications, and revision or removal surgeries serve as primary evidence.
Your attorney can help you obtain records from hospitals and surgical centers.
Is there a class action lawsuit for spinal cord stimulators?
There is no certified class action for spinal cord stimulators as of 2026.
Cases are handled as individual lawsuits within mass tort or MDL proceedings.
This approach allows each patient to seek compensation based on their specific injuries rather than receiving a one-size-fits-all payout.
If you had a spinal cord stimulator implanted and experienced complications, 2026 is the year to take action. Statute of limitations deadlines are approaching for many patients, and early filings position your case for the best possible outcome.
Gather your medical records. Identify your device manufacturer and model. Reach out to a medical device attorney for a free case evaluation.
The companies that made these devices have the resources to fight hard. Making sure your claim is on file puts you in line for compensation when settlements are reached.
